Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 265

1.

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.

Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE.

Atherosclerosis. 2009 Dec;207(2):546-51. doi: 10.1016/j.atherosclerosis.2009.05.013. Epub 2009 May 21.

PMID:
19524924
[PubMed - indexed for MEDLINE]
2.

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.

Mirza MA, Larsson A, Lind L, Larsson TE.

Atherosclerosis. 2009 Aug;205(2):385-90. doi: 10.1016/j.atherosclerosis.2009.01.001. Epub 2009 Jan 9.

PMID:
19181315
[PubMed - indexed for MEDLINE]
3.

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.

Hsu HJ, Wu MS.

Am J Med Sci. 2009 Feb;337(2):116-22. doi: 10.1097/MAJ.0b013e3181815498.

PMID:
19214027
[PubMed - indexed for MEDLINE]
4.

Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.

Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD.

JACC Cardiovasc Imaging. 2008 Sep;1(5):582-91. doi: 10.1016/j.jcmg.2008.05.012.

PMID:
19356485
[PubMed - indexed for MEDLINE]
Free Article
5.

[Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].

Grabysa R, Cholewa M.

Pol Merkur Lekarski. 2008 Oct;25(148):309-14. Polish.

PMID:
19145927
[PubMed - indexed for MEDLINE]
6.

Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.

Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaëlsson K, Tivesten A, Marsell R, Orwoll E, Karlsson MK, Ljunggren O, Mellström D, Lind L, Ohlsson C, Larsson TE.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):219-27. doi: 10.1161/ATVBAHA.110.214619. Epub 2010 Oct 21.

PMID:
20966399
[PubMed - indexed for MEDLINE]
Free Article
7.

Presence of chronic kidney disease and subsequent changes of left ventricular geometry over 4 years in an apparently healthy population aged 60 and older.

Lee YT, Chiu HC, Su HM, Voon WC, Lin TH, Lai WT, Sheu SH.

Hypertens Res. 2008 May;31(5):913-20. doi: 10.1291/hypres.31.913.

PMID:
18712047
[PubMed - indexed for MEDLINE]
8.

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.

Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellström D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE.

Eur J Endocrinol. 2008 Jan;158(1):125-9. doi: 10.1530/EJE-07-0534.

PMID:
18166826
[PubMed - indexed for MEDLINE]
Free Article
9.

Relationship between circulating FGF23 and total body atherosclerosis in the community.

Mirza MA, Hansen T, Johansson L, Ahlström H, Larsson A, Lind L, Larsson TE.

Nephrol Dial Transplant. 2009 Oct;24(10):3125-31. doi: 10.1093/ndt/gfp205. Epub 2009 May 9.

PMID:
19429932
[PubMed - indexed for MEDLINE]
Free Article
10.

Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.

Jovanovich A, Ix JH, Gottdiener J, McFann K, Katz R, Kestenbaum B, de Boer IH, Sarnak M, Shlipak MG, Mukamal KJ, Siscovick D, Chonchol M.

Atherosclerosis. 2013 Nov;231(1):114-9. doi: 10.1016/j.atherosclerosis.2013.09.002. Epub 2013 Sep 13.

PMID:
24125420
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.

J Am Soc Nephrol. 2007 Sep;18(9):2600-8. Epub 2007 Jul 26.

PMID:
17656479
[PubMed - indexed for MEDLINE]
Free Article
12.

Left ventricular mass in hypertensive patients with mild-to-moderate reduction of renal function.

Cerasola G, Nardi E, Mulè G, Palermo A, Cusimano P, Guarneri M, Arsena R, Giammarresi G, Carola Foraci A, Cottone S.

Nephrology (Carlton). 2010 Mar;15(2):203-10. doi: 10.1111/j.1440-1797.2009.01178.x.

PMID:
20470280
[PubMed - indexed for MEDLINE]
13.

Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.

Ulasi II, Arodiwe EB, Ijoma CK.

Ethn Dis. 2006 Autumn;16(4):859-64.

PMID:
17061738
[PubMed - indexed for MEDLINE]
14.

Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.

Testa A, Mallamaci F, Benedetto FA, Pisano A, Tripepi G, Malatino L, Thadhani R, Zoccali C.

J Bone Miner Res. 2010 Feb;25(2):313-9. doi: 10.1359/jbmr.090717.

PMID:
20422622
[PubMed - indexed for MEDLINE]
15.

Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.

Seeherunvong W, Abitbol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M.

Pediatr Nephrol. 2012 Nov;27(11):2129-36. doi: 10.1007/s00467-012-2224-7. Epub 2012 Jun 19.

PMID:
22710695
[PubMed - indexed for MEDLINE]
16.

B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.

Vickery S, Price CP, John RI, Abbas NA, Webb MC, Kempson ME, Lamb EJ.

Am J Kidney Dis. 2005 Oct;46(4):610-20.

PMID:
16183415
[PubMed - indexed for MEDLINE]
17.

Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.

Hansson J, Lind L, Hulthe J, Sundström J.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):297-303. doi: 10.1097/HJR.0b013e3283213108.

PMID:
19387352
[PubMed - indexed for MEDLINE]
18.

Left ventricular hypertrophy in nondiabetic predialysis CKD.

Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G.

Am J Kidney Dis. 2005 Aug;46(2):320-7.

PMID:
16112052
[PubMed - indexed for MEDLINE]
19.

Relation of childhood risk factors to left ventricular hypertrophy (eccentric or concentric) in relatively young adulthood (from the Bogalusa Heart Study).

Toprak A, Wang H, Chen W, Paul T, Srinivasan S, Berenson G.

Am J Cardiol. 2008 Jun 1;101(11):1621-5. doi: 10.1016/j.amjcard.2008.01.045. Epub 2008 Apr 2.

PMID:
18489940
[PubMed - indexed for MEDLINE]
20.

Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.

Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J.

Am J Kidney Dis. 2013 Jan;61(1):67-73. doi: 10.1053/j.ajkd.2012.06.022. Epub 2012 Aug 9.

PMID:
22883134
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk